Litcius/Paper detail

Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases

Nicolò Schifano, Paolo Capogrosso, Luca Boeri, Giuseppe Fallara, Stefania Chiappini, Matthew Rewhorn, Ömer Onur Çakır, Hannah Harvey, Fabio Castiglione, Hussain M. Alnajjar, Asıf Muneer, Federico Dehò, Fabrizio Schifano, Francesco Montorsi, Andrea Salonia

2022International Journal of Impotence Research12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse Event Reporting SystemPeyronie's diseasePharmacovigilanceAdverse effectFinasterideFood and drug administrationDatabaseInternal medicineErectile dysfunctionPharmacologyCancerComputer scienceProstateSexual function and dysfunction studiesHormonal and reproductive studiesReproductive Health and Contraception
Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases | Litcius